Skip to main content
Signal8

Markus Richard

SEC insider (Form 3/4/5 filer). CIK 0002056093. Chief Medical Officer at Arcus Biosciences, Inc. (RCUS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in HAYWARD, CA.

Companies Markus Richard has filed insider reports for

  • Arcus Biosciences, Inc. (RCUS): Officer, Chief Medical Officer
Markus Richard profile photo

Markus Richard

CIK: 0002056093

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcus Biosciences, Inc. logo
RCUS

Arcus Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Jan 23, 2026
    Award
    Direct
    24K shares-
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Dec 17, 2025
    Sale
    Direct
    4.5K shares at avg. $22.16$100K
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Dec 16, 2025
    Sale
    Direct
    5.1K shares at avg. $21.88$111K
  • Arcus Biosciences, Inc. logo
    RCUS

    Arcus Biosciences, Inc.

    Feb 10, 2025
    Award
    Direct
    75.2K shares-

1-4 of 4